Tags ArchivesGrant

‘Vroegefaseproject’ loan granted to commercialize PACT, the platelet function test image

UTRECHT, THE NETHERLANDS, JULY 16th 2018 – The NWO domain Applied and Technical Sciences (TTW, formerly known as the Technology Foundation STW) has granted a loan for the Take-off phase 2 project ‘PACT, a new diagnostic tool to assess platelet function in the bleeding patient’.  The grant in the amount of € 150.000 will be used for the commercial application of the PACT to improve platelet diagnostics in patients at risk of bleeding by implementing PACT in the diagnostic clinical setting and to obtain CE marking for entry onto the (inter)national market. Entrepreneurship The Take-off phase 2 program is part of a science-wide funding instrument of ZonMw and NWO, which is financed by the Dutch Ministry of Economic Affairs and Climate ...

Continue Reading

U-PACT receives MIT R&D collaborative project grant from the Economic Board Utrecht image

UTRECHT, THE NETHERLANDS, JANUARY 12th 2017 – U-PACT B.V., the molecular diagnostics company that develops technology to provide comprehensive tools for accurate assessment of bleeding risk, has received the MIT R&D collaborative project grant from the Economic Board Utrecht. The application entitled ‘PACT, a platelet activation test that predicts bleeding risk’ was rated as more innovative compared to other applications with respect to its product development, and judged much better than average regarding its economic value. In collaboration with U-Protein Express B.V., U-PACT B.V. will use this grant to develop and validate novel reagents for its platelet function test PACT. For more information on the PACT, please contact Dr. Suzanne Korporaal, C.O.O. at J.A.Korporaal@U-PACT.com. For more information on U-PACT B.V., please contact ...

Continue Reading

This is a unique website which will require a more modern browser to work!

Please upgrade today!